Dosie™ validated in I-PDT clinical trial to treat Malignant Central Airway Obstruction
Cancers, May 2023 (Special Issue: Remote-Controlled Therapeutics for Cancer Therapy and Imaging) – Currently, there are no effective...
top of page
Simphotek | Medical Devices
Our Recent Posts
Archive
Tags
Gene Parilov
Mar 14, 2023
Dosie™ can model moving light to improve outcomes of intracavitary PDT in fighting Mesothelioma
SPIE BiOS, 2023 (Optical Methods for Tumor Treatment and Detection) – We introduce a new feature of our Dosie™ modeling software that...
Gene Parilov
Apr 13, 2021
Simphotek partners with Penn in fighting Mesothelioma
Simphotek partners with Penn in developing an In Situ System for Treatment of Mesothelioma
Mary
Aug 17, 2020
Simphotek announces selection as a MedTech company
Simphotek has been selected as one of the showcase companies for the 2020-2021 NCI SBIR Investor Initiatives. As a MedTech company, it...
Gene
Jul 1, 2019
Dosie™ adds modeling Interstitial Photodynamic Therapy (I-PDT)
International Photodynamic Association World Congress, 2019 (Boston, USA) – Simphotek announces a new addition to its simulation software...
Gene
Jan 31, 2019
Dosie™ modeling software predicts better PDT outcomes.
SPIE BiOS, 2019 (Optical Methods for Tumor Treatment and Detection) – We introduce our Dosie modeling software that helps in predicting...
Gene
Jan 25, 2017
Treatment planning and real-time dosimetry for I-PDT
Cancers, 2017 (Special Issue: Photodynamic Cancer Therapy) – Treatment planning and real-time dosimetry optimize and further advance the...
Gene
Apr 1, 2016
Simphotek advances treatment of cancer using light-drug interacitons
TechNews, Apr 2016 (NJ Tech Council) – Simphotek collaborates with leading cancer research institutions to address a critical unmet need:...
Gene
Jan 10, 2016
Simphotek accelerates PDT entry into the era of personalized medicine
New Jersey Tech Weekly, Jan 10, 2016 – What happens when you optimize a cancer treatment using software? A possible organ-sparing,...
Mary
Oct 29, 2015
State Resources Help Newark-based Simphotek Aid World’s Leading Cancer Centers
NJEDA, Oct 2015 (Feature article) – Simphotek advances light-based treatment of cancer. Simphotek is working with its academic partners...
bottom of page